Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…Objectives The prognostic implications of rheumatoid arthritis (RA) in patients with non-tuberculous mycobacterial pulmonary d…
…idely used and effective interventions for CRF in patients with breast cancer. However, owing to the variety of non-pharmacological intervent…
… outweigh cardiovascular priorities, particularly during active cancer treatment, with age further limiting self-care engagement. Phas…
…tion was 87.3±106.1 µm with aflibercept and 113.1±136.7 µm with faricimab. Adjusted mean reductions were 95.4 µm and 99.8 µm, respectivel…
…s 70 years), present with haemorrhagic (as opposed to ischaemic stroke, p<0.001) and have a higher comorbidity burden. The mortality r…
…therapy), and 18 months of adjuvant therapy with relugolix plus enzalutamide. Primary outcomes include pathologic CR rate and minimal residu…
…, coupled with rapid clinical and biochemical improvement after atorvastatin discontinuation, supported a diagnosis of rhabdomyolysis due to…
…€11 100). Extrapolated to the annual distribution volume at the St Thomas Pharmacy, the annual loss from unused medication would be 900 000 Kr (€1…
…T 1-h PG and 96.1% (95% CI 94.7% to 97.3%) for OGTT 2-h PG. For pre-diabetes, the AUC was 71.8% (95% CI 67.9% to 75.8%) for OGTT 1-h PG and …
…its combination with PD-1 blockade (camrelizumab, albumin-bound paclitaxel and cisplatin/paclitaxel and cisplatin, Cam+nab-TP/TP; n=41), f…
…ndrogen deprivation therapy (ADT) improves survival in advanced prostate cancer but may lead to debilitating side effects, including sarcopenic…
…Background Food insecurity, limited access to affordable and healthy foods, during pregnan…